| Protamine |
| SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, (Exclude: Coronary Care Unit) |
| SCOPE (Staff): Medical, Nursing, Pharmacy |
Printed versions of this document SHOULD NOT be considered up to date / current
Exclusions
| Paediatrics (seek Paediatrician advice) and all other Wards |
Preamble
See Appendix 1 for full version of this Drug Guideline! |
Related Documents
References
 |
Alfred Health (2019, April). Therapeutic Anticoagulation wit Unfractionated Heparin. Alfred Health. Retrieved April 2019 from personal communication. |
|
Barwon Health (2018, March). Protamine Drug Protocol. Barwon Health. Retrieved February, 2019 from personal communication. |
 |
CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved April 28, 2019 from |
|
MIMS Online. (2019, April). MIMS Online, Protamine Sulfate Injection BP product information. Retrieved April 22, 2019 from |
|
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 22, 2019, from |
|
The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved April 22, 2019, from |
|
Walters Kluwer. (2019). UpToDate, Drug Interaction section. Retrieved April 22, 2019, from |
Appendix
| Reg Authority: Medication Safety & Governance Committee (MSGC) |
Date Effective: 01/10/2020 |
| Review Responsibility: Pharmacist - Rotational |
Date for Review: 30/09/2024 |
Protamine - DRG0030 - Version: 5 - (Generated On: 13-07-2025 05:51) |
